November 6, 2024

Certara Reports Third Quarter 2024 Financial Results

October 28, 2024

Certara to Participate in the Stephens Annual Investment Conference

October 16, 2024

Certara Appoints John Reynders as New Independent Board Member 

October 9, 2024

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

October 2, 2024

Certara Completes Acquisition of Chemaxon

September 24, 2024

Certara’s Simcyp Consortium Celebrates 25th Anniversary

September 18, 2024

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

August 21, 2024

Certara to Participate in Upcoming Investor Conferences

August 15, 2024

Certara Launches Phoenix™ Version 8.5 Drug Development Software

August 6, 2024

Certara Reports Second Quarter 2024 Financial Results